AR126304A1 - PHARMACEUTICAL COMPOSITION FOR THE SUPPLY OF MEDICINES - Google Patents
PHARMACEUTICAL COMPOSITION FOR THE SUPPLY OF MEDICINESInfo
- Publication number
- AR126304A1 AR126304A1 ARP210103237A ARP210103237A AR126304A1 AR 126304 A1 AR126304 A1 AR 126304A1 AR P210103237 A ARP210103237 A AR P210103237A AR P210103237 A ARP210103237 A AR P210103237A AR 126304 A1 AR126304 A1 AR 126304A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- pharmaceutically acceptable
- medicines
- supply
- pharmaceutical composition
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 5
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 abstract 2
- 229930182837 (R)-adrenaline Natural products 0.000 abstract 2
- 229960005139 epinephrine Drugs 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012876 carrier material Substances 0.000 abstract 1
- 238000000151 deposition Methods 0.000 abstract 1
- 150000002016 disaccharides Chemical class 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 210000002850 nasal mucosa Anatomy 0.000 abstract 1
- 210000001331 nose Anatomy 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Abstract
Reivindicación 1: Una composición farmacéuticamente aceptable, tal composición está en la forma de un polvo secado por aspersión, caracterizada porque comprende una mezcla de: (a) una cantidad de dosis farmacológicamente efectiva de epinefrina, o una de sus sales farmacéuticamente aceptables; y (b) un material portador farmacéuticamente aceptable, tal material portador comprende una combinación de un disacárido y un material polimérico. Reivindicación 18: Un dispositivo aplicador nasal adecuado y/o adaptado para la administración de una composición como se define en cualquiera de las reivindicaciones 1 a 16 a la nariz, caracterizado porque comprende, o está adjunto y/o unido a un reservorio, dentro del cual dicha composición está contenida, y cuyo dispositivo aplicador está configurado de manera que dicho dispositivo, al accionarse, es capaz de depositar una dosis eficaz de epinefrina, o una sal de la misma, en la mucosa nasal.Claim 1: A pharmaceutically acceptable composition, such composition being in the form of a spray-dried powder, characterized in that it comprises a mixture of: (a) a pharmacologically effective dose amount of epinephrine, or a pharmaceutically acceptable salt thereof; and (b) a pharmaceutically acceptable carrier material, such carrier material comprising a combination of a disaccharide and a polymeric material. Claim 18: A nasal applicator device suitable and/or adapted for the administration of a composition as defined in any of claims 1 to 16 to the nose, characterized in that it comprises, or is attached and/or attached to a reservoir, within the which said composition is contained, and whose applicator device is configured such that said device, when actuated, is capable of depositing an effective dose of epinephrine, or a salt thereof, in the nasal mucosa.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP210103237A AR126304A1 (en) | 2021-11-24 | 2021-11-24 | PHARMACEUTICAL COMPOSITION FOR THE SUPPLY OF MEDICINES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP210103237A AR126304A1 (en) | 2021-11-24 | 2021-11-24 | PHARMACEUTICAL COMPOSITION FOR THE SUPPLY OF MEDICINES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR126304A1 true AR126304A1 (en) | 2023-10-04 |
Family
ID=88679289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210103237A AR126304A1 (en) | 2021-11-24 | 2021-11-24 | PHARMACEUTICAL COMPOSITION FOR THE SUPPLY OF MEDICINES |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR126304A1 (en) |
-
2021
- 2021-11-24 AR ARP210103237A patent/AR126304A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2022000033A1 (en) | Pharmaceutical composition for nasal delivery | |
| AR076624A1 (en) | SUPPLY OF TWO OR MORE MEDICINES THROUGH A SINGLE DOSE SELECTION AND A SINGLE DISPENSATION INTERFACE | |
| ECSP099635A (en) | LIQUID FORMULATIONS THAT FORM A DERMAL LAYER FOR THE RELEASE OF SKIN DRUGS | |
| PE20180411A1 (en) | PHARMACEUTICAL FORMULATIONS INCLUDING TENOFOVIR AND EMTRICITABIN | |
| ECSP045465A (en) | DOSAGE FORMS AND COMPOSITIONS FOR THE OSMOTE ADMINISTRATION OF TWO VARIABLES OF OXICODONA | |
| RS53243B (en) | Cartridge, pharmaceutical dispenser for solid pharmaceutical portions and applications of said cartridge and said pharmaceutical dispenser | |
| ECSP10010224A (en) | LUTEINIZING HORMONE LIQUID FORMULATIONS (LH). | |
| CL2021001810A1 (en) | Combination of dextromethorphan and bupropion for the treatment of depression | |
| CL2017001859A1 (en) | Dry powder inhaler comprising fluticasone propionate and salmeterol xinaphosphate | |
| AR099364A1 (en) | MEDICATION INHALER | |
| BR112014014795A2 (en) | immediate release multi-unit pellet system | |
| AR104201A1 (en) | ADMINISTRATION DEVICE FOR NASAL MEDICATION | |
| PE20080329A1 (en) | TREATMENT OF CYST FIBROSIS WITH ANTIBIOTICS VIA A DRUG IN AEROSOL | |
| AR046036A1 (en) | RISEDRONATE COMPOSITIONS AND METHODS FOR USE | |
| BR112018000039A2 (en) | single use release device | |
| CO2022003543A2 (en) | Long-acting injectable formulations of ketamine pamoate salts | |
| AR126304A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE SUPPLY OF MEDICINES | |
| AR107935A1 (en) | USE OF COMPOUND 6- (4- (2,3-DIMETHYLPHENOXY) PIPERIDIN-1-IL) METHYL) PYRIMIDINE-2,4 (1H, 3H) -DIONA OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME TO PREPARE A MEDICINAL, COMBINATION AND COMPOSITION PHARMACEUTICAL UNDERSTANDING SUCH COMPOUND | |
| AR111803A1 (en) | DERIVED FROM CICLOPENTAN [G] QUINAZOLIN-4-ONA AND ITS EMPLOYMENT IN THE TREATMENT OF CANCER RESISTANT TO PLATINUM | |
| CO2018009543A2 (en) | Extended release pharmaceutical composition comprising cysteamine or salt thereof | |
| ES1060042Y (en) | MEDICINES SUPPLY DEVICE | |
| AR111699A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING BETAHISTINA | |
| DOP2022000004A (en) | PHARMACEUTICAL COMPOSITIONS RESISTANT TO THE DISCHARGE OF DOSES THAT INCLUDE VENIRUNAD | |
| AR104177A1 (en) | SYSTEM FOR THE ADMINISTRATION OF DRUGS IN THE LAGRIMAL GLAND | |
| CL2021000627A1 (en) | Pharmaceutical compositions suitable for joint release and their use in the treatment of joint pain |